Intravenous (IV) administration is considered as the primary route of administration for many anticancer agents. However, there are some limitations such as the possibility of postinjection infections and catheter failure.
Sarcoidosis is a multi-organ system autoimmune disorder characterized by the presence of non-caseating granuloma formation within one or more organ systems [1]. The majority of cases present with lung involvement, however 30-50% of cases have extra-pulmonary involvement at the time of clinical presentation [2].
Cutaneous metastases of the different visceral malignancies (0.7-9%) and especially of the lung cancer are rare and worsen the prognosis (1-12%). We report the case of a 55 year old gentleman who presented with a right upper lung lesion diagnosed as poorly differentiated squamous cell carcinoma and was treated with concurrent chemo radiation therapy followed by adjuvant chemotherapy.
The combination therapy of the epidermal growth factor receptor inhibitor, cetuximab (Cmab), and paclitaxel (PTX) can be possibility effective for treatment of large cervical lymph-node metastasis. Here, we report a case of a patient with large cervical lymph-node metastasis treated with Cmab+PTX in whom complete response (CR) was maintained even after treatment discontinuation at the request of the patient. The patient was a 55-year-old female with a chief complaint of left-tongue pain...
Cystic degeneration is common in Renal Cell Carcinoma (RCC) in about 15% of the cases [1]. This has to be differentiated from the cystic variant of RCC. This is difficult due to the expanding subtypes being described as the number of cases seen and being studied are increasing. A seemingly cystic degeneration in RCC can easily be a multilocular variant of cystic RCC with solid component of less than 25%. The prognosis of the patient varies according to the diagnosis and thus the aggressiveness of the treatment needs to be tailored. Here we present such a diagnostic dilemma...
We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.